AF488 Anti-Human CD28 Antibody[CD28.2]

AF488 Anti-Human CD28 Antibody[CD28.2]

Introducing the AF488 Anti-Human CD28 Antibody [CD28.2], a cutting-edge product designed to revolutionize the field of immunology research. This antibody, labeled with AF488, offers exceptional specificity and sensitivity in detecting the CD28 antigen on human cells.

The AF488 Anti-Human CD28 Antibody [CD28.2] is meticulously engineered using state-of-the-art techniques, ensuring its high affinity and reliability. Its advanced formulation guarantees optimal performance, making it an indispensable tool for various applications, including flow cytometry, immunofluorescence, and immunohistochemistry.

With its exceptional specificity, this antibody enables precise identification and characterization of CD28-expressing cells, facilitating in-depth investigations into immune responses, T-cell activation, and co-stimulatory pathways. Its remarkable sensitivity allows for the detection of even low levels of CD28 expression, enabling researchers to explore subtle variations in immune cell populations.

The AF488 Anti-Human CD28 Antibody [CD28.2] is meticulously validated to ensure consistent and reproducible results. Its exceptional performance is further enhanced by its compatibility with a wide range of experimental conditions, making it suitable for diverse research settings.

This product is supplied in a convenient and user-friendly format, ensuring ease of use and storage. Each vial contains a precisely measured quantity of the antibody, maintaining its stability and integrity. The AF488 Anti-Human CD28 Antibody [CD28.2] is rigorously quality-controlled to meet the highest standards, guaranteeing reliable and accurate results.

In summary, the AF488 Anti-Human CD28 Antibody [CD28.2] is a cutting-edge tool that empowers researchers to delve deeper into the intricate mechanisms of the immune system. Its exceptional specificity, sensitivity, and reliability make it an invaluable asset in immunology research, enabling groundbreaking discoveries and advancements in the field.